免疫代谢中的IRG1-伊他康酸轴:炎症性疾病中的机械作用和治疗潜力
Yang Liu1, Pengyu Zhang1, Weijie Kong1
1Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
Frontiers in immunology
|February 26, 2026
概括
伊塔科纳酸,一种与炎症相关的代谢物,在免疫反应中起着双重作用. 这篇评论探讨了它的生产,信号和治疗炎症疾病的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢过程中的代谢.
- 生物化学 生物化学
背景情况:
- 免疫细胞和微环境受到代谢产物的影响.
- 伊塔科纳酸是一种三碳酸 (TCA) 循环绕道代谢物,由免疫反应基因1 (IRG1) 生产.
- 在炎症中,尤其是M1极化巨细胞中,IRG1-伊塔康酸轴至关重要.
研究的目的:
- 审查伊塔科纳酸的生产机制,生物化学性质,信号通路和跨细胞效应.
- 强调其在调节炎症反应中的双重作用.
- 为炎症性疾病提供理论基础和治疗策略.
主要方法:
- 对现有文献进行系统审查.
- 检查伊塔科纳酸在急性和慢性炎症中的作用.
- 分析其对免疫耐受性和癌症治疗的影响.
主要成果:
- 伊塔科纳特通过抑制酸脱酶 (SDH) 和在急性炎症期间激活抗氧化途径来限制炎症.
- 伊塔科纳酸可以通过抑制抗原呈现来促进慢性炎症或瘤微环境中的免疫抑制.
- IRG1-itaconate轴表现出动态的,取决于环境的监管特征.
结论:
- 伊塔科纳酸的双向性和环境依赖性是免疫平衡和疾病进展的关键.
- 了解伊塔科纳酸的分子机制为精确干预炎症性疾病提供了潜力.
- 需要进一步研究和临床翻译基于伊塔康酸盐的方法.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
604
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
604
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
658
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
658
Inflammatory Bowel Disease IV: Pharmacological Management
860
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
860
Drugs for Treatment of Ulcerative Colitis in IBD
577
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
577
T Cell Types and Functions
2.9K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.9K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
972
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
972


